Atacand and Lidoderm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atacand (candesartan cilexetil) and Lidoderm (lidocaine). Common drug interactions include muscle spasms among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Atacand and Lidoderm. It is created by eHealthMe based on reports of 43 people who take the same drugs from the FDA, and is updated regularly.

What is Atacand?

Atacand has active ingredients of candesartan cilexetil. It is often used in high blood pressure. eHealthMe is studying from 22,473 Atacand users. Check the latest studies of Atacand.

What is Lidoderm?

Lidoderm has active ingredients of lidocaine. It is often used in pain. eHealthMe is studying from 10,524 Lidoderm users. Check the latest studies of Lidoderm.



On Jul, 20, 2026

43 people who take Atacand and Lidoderm together, and have interactions are studied.

Atacand and Lidoderm drug interactions.

What are the common drug interactions of Atacand and Lidoderm, by gender? *:

female:

  1. Muscle spasms (muscle contraction)
  2. Nerve injury
  3. Renal artery stenosis (narrowing of renal artery)
  4. Renal failure (kidney dysfunction)
  5. Renal failure chronic (long lasting kidney dysfunction)
  6. Stress
  7. Alopecia (absence of hair from areas of the body)
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Asthenia (weakness)
  10. Cardiac failure congestive

male:

  1. Renal failure (kidney dysfunction)
  2. Anaemia (lack of blood)
  3. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  4. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  5. Anxiety
  6. Constipation
  7. Death
  8. Hypercholesterolaemia (high levels of cholesterol in the blood)
  9. Dyspnoea (difficult or laboured respiration)
  10. Dyspnoea exertional (breathlessness or shortness of breath)

What are the common drug interactions of Atacand and Lidoderm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthma
  2. Blood cholesterol increased
  3. Constipation
  4. Acute myocardial infarction (acute heart attack)
  5. Angiopathy (generic term for a disease of the blood vessels)
  6. Hepatic steatosis (fatty liver disease)
  7. Hyperlipidaemia (presence of excess lipids in the blood)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Myocarditis (inflammation of heart muscle myocardium)
  10. Pneumonia

40-49:

n/a

50-59:

  1. Depression
  2. Sick sinus syndrome (a collection of heart rhythm disorders)
  3. Visual impairment
  4. Weight increased
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Cardiac murmur (an heart sound in valve abnormality)
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Fatigue (feeling of tiredness)
  9. Haematochezia (passage of stools containing blood)
  10. Heart rate irregular

60+:

  1. Renal failure (kidney dysfunction)
  2. Chronic kidney disease
  3. Aortic dilatation
  4. Asthenia (weakness)
  5. Bone disorder
  6. Decreased interest
  7. Deformity (disfigurement)
  8. Dyspnoea (difficult or laboured respiration)
  9. Emotional distress
  10. Failure to thrive (inadequate weight gain and physical growth in children)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 16.28%
  2. Multiple Myeloma (cancer of the plasma cells): 6 people, 13.95%
  3. Cardiac Failure Congestive: 6 people, 13.95%
  4. Cardiac Disorder: 5 people, 11.63%
  5. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 9.30%
  6. Depression: 3 people, 6.98%
  7. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Atacand and Lidoderm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atacand and Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atacand:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lidoderm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atacand and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lidoderm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on candesartan cilexetil and lidocaine (the active ingredients of Atacand and Lidoderm, respectively), and Atacand and Lidoderm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: